2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases
US11111217B2 · kind B2 · utility
0Cited by
8References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2020 |
| Grant date | Sep 7, 2021 |
| Priority date | — |
| Expiry date | Oct 13, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compound 2-(4-tert-Butylphenyl)-1H-benzo[d]imidazol-5-ol: and its use are disclosed. The compound activates Ppargc1a and, as a consequence, is useful for treating neuroinflammation and for treating a variety of neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.